Early treatment is associated with improved outcomes in patients with rheumatoid arthritis
(RA), suggesting that a'window of opportunity', in which the disease is most susceptible to …

The concept of a 'window of opportunity'in treating a disease assumes the existence of a
time frame during which the trajectory of the disease can be effectively and permanently …

Background During the transition to rheumatoid arthritis (RA) many patients pass through a
phase characterised by the presence of symptoms without clinically apparent synovitis …

Introduction Patients with clinically suspect arthralgia (CSA) have, according to their
rheumatologists, an increased risk of rheumatoid arthritis (RA), but their actual outcome is …

Background The phase of arthralgia is the earliest moment to clinically recognize patients
who may develop Rheumatoid Arthritis (RA). Previous imaging studies in the arthralgia …

Objective The use of magnetic resonance imaging (MRI)–detected inflammation and joint
damage in the diagnosis of rheumatoid arthritis is recommended by a European League …

Objective Anti-carbamylated protein (anti-CarP) antibodies are reported to associate with
more radiographic progression within the total rheumatoid arthritis (RA) population and anti …

Objective Disease-modifying antirheumatic drug (DMARD)-free sustained remission, the
sustained absence of synovitis after cessation of DMARD therapy, is a relevant long-term …

Introduction Anti-carbamylated protein (anti-CarP) antibodies have been described in
rheumatoid arthritis (RA) and arthralgia patients at risk of developing RA. To what extent …

Pregnant women with bleeding disorders require specialised peripartum care to prevent
postpartum haemorrhage (PPH). If third trimester coagulation factor levels are< 0.50 IU mL …